Pressure injuries are a considerable cause of pain and distress to patients and represent a significant financial burden to health care systems. The cost of a stage IV pressure ulcer is between $70-$150,000 and is the second most common hospital billing claim1.
The Frontier Therapeutics Team are excited to be showcasing Dermisplus® Prevent at this year’s WOCN Conference.
Dermisplus Prevent is designed to redistribute peak pressures over a wider surface area, reducing the risk of pressure related tissue damage. Versatile and flexible, Dermisplus Prevent can be used on intact skin, anywhere on the body.
Pressure injuries from medical devices are common and can cause significant morbidity in patients of all ages. Use Dermisplus® Prevent underneath the device itself to help reduce the risk of device-related pressure injuries.
For more information visit www.frontier-therapeutics.com/dermisplus
About Frontier
Frontier Therapeutics are a Frontier Medical Group company.
Frontier Medical Group Frontier Medical Group, based in Blackwood, South Wales, is a market leading provider of a range of specialist medical devices to healthcare professionals and end users both in the UK and internationally. Frontier’s products contribute significantly to the safety and wellbeing of end users and patients, specifically in Skin/Wound Care and Infection Prevention.
1. Lyder CH, Wang Y, Metersky M, Curry M, Kliman R, Verzier NR, Hunt DR. Hospital-acquired pressure ulcers: results from the national Medicare Patient Safety Monitoring System study. J Am Geriatr Soc 2012 Sep;60(9):1603-8.
Pressure injuries are a considerable cause of pain and distress to patients and represent a significant financial burden to health care systems. The cost of a stage IV pressure ulcer is between $70-$150,000 and is the second most common hospital billing claim1.
The Frontier Therapeutics Team are excited to be showcasing Dermisplus® Prevent at this year’s WOCN Conference.
Dermisplus Prevent is designed to redistribute peak pressures over a wider surface area, reducing the risk of pressure related tissue damage. Versatile and flexible, Dermisplus Prevent can be used on intact skin, anywhere on the body.
Pressure injuries from medical devices are common and can cause significant morbidity in patients of all ages. Use Dermisplus® Prevent underneath the device itself to help reduce the risk of device-related pressure injuries.
For more information visit www.frontier-therapeutics.com/dermisplus
About Frontier
Frontier Therapeutics are a Frontier Medical Group company.
Frontier Medical Group Frontier Medical Group, based in Blackwood, South Wales, is a market leading provider of a range of specialist medical devices to healthcare professionals and end users both in the UK and internationally. Frontier’s products contribute significantly to the safety and wellbeing of end users and patients, specifically in Skin/Wound Care and Infection Prevention.
1. Lyder CH, Wang Y, Metersky M, Curry M, Kliman R, Verzier NR, Hunt DR. Hospital-acquired pressure ulcers: results from the national Medicare Patient Safety Monitoring System study. J Am Geriatr Soc 2012 Sep;60(9):1603-8.